
Solesence, Inc. Common Stock
SLSNNASDAQConsumer DefensiveHousehold & Personal Products
Latest quote
$0.95
−$0.0407 · -4.11%
SLSN company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
75
Undervalued
Momentum
19
Strong Down
Sentiment
50
Mixed
Risk resilience
23
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSolesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- Headquarters
- US
- CEO
- Kevin Cureton
- Listed since
- Nov 26, 1997
- Employees
- 115
Market position
- Volume
- 11.83K
- 0.14× average
- Average volume
- 82.11K
- Average daily volume
- Market cap
- 67.1M USD
- Beta
- 1.26
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 135.58M USD
- EV / EBITDA
- 36.73×
- Earnings yield
- 1.59%
- Free cash flow yield
- -9.52%
Profitability & efficiency
- Return on equity
- 10.15%
- Return on assets
- 3.58%
- Return on invested capital
- 3.58%
Financial health
- Current ratio
- 2.07×
- Altman Z-score
- -0.8
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62.06M USD | 52.35M USD | 37.3M USD | 37.32M USD | 29.48M USD |
| Cost of goods sold | 46.04M USD | 36.16M USD | 29.47M USD | 28.96M USD | 20.79M USD |
| Gross profit | 16.03M USD | 16.19M USD | 7.83M USD | 8.36M USD | 8.69M USD |
| Research and development | 4.08M USD | 3.84M USD | 3.84M USD | 3.04M USD | 2.24M USD |
| Selling, general, and administrative | 10.38M USD | 7.22M USD | 7.53M USD | 7.58M USD | 3.9M USD |
| Operating expenses | 14.46M USD | 11.06M USD | 11.37M USD | 10.62M USD | 6.13M USD |
| Interest expense | 931K USD | 670K USD | 838K USD | 382K USD | 1.15M USD |
| Depreciation and amortization | 897K USD | 928K USD | 742K USD | 567K USD | 454K USD |
| Operating income | 1.57M USD | 5.13M USD | −3.55M USD | −2.26M USD | 2.56M USD |
| Net income | 1.79M USD | 4.24M USD | −4.39M USD | −2.62M USD | 2.32M USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- -0
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
ETFs holding SLSN
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research SLSNresearch.disclaimer

